DOI QR코드

DOI QR Code

Act on the Registration and Evaluation of Chemicals (K-REACH) and replacement, reduction or refinement best practices

  • Ha, Soojin (Department of Mechanistic Toxicology, Ewha Womans University College of Pharmacy) ;
  • Seidle, Troy (Research and Toxicology Department, Humane Society International) ;
  • Lim, Kyung-Min (Department of Mechanistic Toxicology, Ewha Womans University College of Pharmacy)
  • Received : 2016.09.28
  • Accepted : 2016.11.04
  • Published : 2016.01.01

Abstract

Objectives Korea's Act on the Registration and Evaluation of Chemicals (K-REACH) was enacted for the protection of human health and the environment in 2015. Considering that about 2000 new substances are introduced annually across the globe, the extent of animal testing requirement could be overwhelming unless regulators and companies work proactively to institute and enforce global best practices to replace, reduce or refine animal use. In this review, the way to reduce the animal use for K-REACH is discussed. Methods Background of the enforcement of the K-REACH and its details was reviewed along with the papers and regulatory documents regarding the limitation of animal experiments and its alternatives in order to discuss the regulatory adoption of alternative tests. Results Depending on the tonnage of the chemical used, the data required ranges from acute and other short-term studies for a single exposure route to testing via multiple exposure routes and costly, longer-term studies such as a full two-generation reproducibility toxicity. The European Registration, Evaluation, Authorization and Restriction of Chemicals regulation provides for mandatory sharing of vertebrate test data to avoid unnecessary duplication of animal use and test costs, and obligation to revise data requirements and test guidelines "as soon as possible" after relevant, validated replacement, reduction or refinement (3R) methods become available. Furthermore, the Organization for Economic Cooperation and Development actively accepts alternative animal tests and 3R to chemical toxicity tests. Conclusions Alternative tests which are more ethical and efficient than animal experiments should be widely used to assess the toxicity of chemicals for K-REACH registration. The relevant regulatory agencies will have to make efforts to actively adopt and uptake new alternative tests and 3R to K-REACH.

Keywords

References

  1. US Government Accountability Office. Toxic Substances Control Act: preliminary observations on legislative changes to make TSCA more effective; 1994 [cited 2016 Dec 27]. Available from: http://www.gao.gov/products/T-RCED-94-263.
  2. Kim KY, Shin SE, No KT. Assessment of quantitative structure-activity relationship of toxicity prediction models for Korean chemical substance control legislation. Environ Health Toxicol 2015;30 Suppl:s2015007. https://doi.org/10.5620/eht.e2015007
  3. Yoon C, Ham S, Park J, Kim S, Lee S, Lee K, et al. Comparison between the chemical management contents of laws pertaining to the Ministry of Environment and the Ministry of the Employment and Labor. J Environ Health Sci 2014;40(5):331-345 (Korean).
  4. Park D. Major concerns regarding lung injury and related health conditions caused by the use of humidifier disinfectant. Environ Health Toxicol 2016;31:e2016014. https://doi.org/10.5620/eht.e2016014
  5. Paek D, Koh Y, Park DU, Cheong HK, Do KH, Lim CM, et al. Nationwide study of humidifier disinfectant lung injury in South Korea, 1994-2011. Incidence and dose-response relationships. Ann Am Thorac Soc 2015;12(12):1813-1821. https://doi.org/10.1513/AnnalsATS.201504-221OC
  6. Hong S. Understanding Asian green chemistry regulations: chemicals substitution. Chim Oggi 2015;33(1):63-64.
  7. Ministry of Government Legislation. Act on the Registration and Evaluation, etc. of Chemical Substances [cited 2014 Dec 30]. Available from: http://www.law.go.kr/lsInfoP.do?lsiSeq=140402#0000 (Korean).
  8. United Nations Economic Commission for Europe. Globally harmonized system of classification and labelling of chemicals (GHS): third revised edition; 2009 [cited 2016 Dec 15]. Available from: https://www.unece.org/trans/danger/publi/ghs/ghs_rev03/03files_e.html.
  9. Ball N, Bartels M, Budinsky R, Klapacz J, Hays S, Kirman C, et al. The challenge of using read-across within the EU REACH regulatory framework; how much uncertainty is too much? Dipropylene glycol methyl ether acetate, an exemplary case study. Regul Toxicol Pharmacol 2014;68(2):212-221. https://doi.org/10.1016/j.yrtph.2013.12.007
  10. Ministry of Agriculture, Food and Rural Affairs. Animal protection and welfare survey report 2015 [cited 2016 Dec 15]. Available from: http://www.mafra.go.kr/list.jsp?&newsid=155448053§ion_id=b_sec_1&pageNo=1&year=2016&listcnt=10&board_kind=C&board_skin_id=C3&depth=1&division=B&group_id=3&menu_id=1125&reference=&parent_code=3&popup_yn=&tab_yn=N (Korean).
  11. Pedersen F, de Bruijn J, Munn S, van Leeuwen K. Assessment of additional testing needs under REACH: effects of (Q)SARS, risk based testing and voluntary industry initiatives; 2003 [cited 2016 Dec 15]. Available from: http://home.kpn.nl/reach/downloads/reachtestingneedsfinal.pdf.
  12. van der Jagt K, Munn S, Torslov J, de Bruijn J. Alternative approaches can reduce the use of test animals under REACH; 2004 [cited 2016 Dec 15]. Available from: http://publications.jrc.ec.europa.eu/repository/bitstream/JRC29111/EUR%2021405%20EN.pdf.
  13. Hartung T, Rovida C. Chemical regulators have overreached. Nature 2009;460(7259):1080-1081. https://doi.org/10.1038/4601080a
  14. Leist M, Hartung T. Inflammatory findings on species extrapolations: humans are definitely no 70-kg mice. Arch Toxicol 2013;87(4):563-567. https://doi.org/10.1007/s00204-013-1038-0
  15. McGonigle P, Ruggeri B. Animal models of human disease: challenges in enabling translation. Biochem Pharmacol 2014;87(1):162-171. https://doi.org/10.1016/j.bcp.2013.08.006
  16. Pastoor T, Stevens J. istorical perspective of the cancer bioassay. Scand J Work Environ Health 2005;31 Suppl 1:129-140.
  17. Holmes AM, Solari R, Holgate ST. Animal models of asthma: value, limitations and opportunities for alternative approaches. Drug Discov Today 2011;16(15-16):659-670. https://doi.org/10.1016/j.drudis.2011.05.014
  18. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, Lee DH, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 2012;33(3):378-455. https://doi.org/10.1210/er.2011-1050
  19. Olson H, Betton G, Stritar J, Robinson D. The predictivity of the toxicity of pharmaceuticals in humans from animal data--an interim assessment. Toxicol Lett 1998;102-103:535-538. https://doi.org/10.1016/S0378-4274(98)00261-6
  20. Food and Drug Administration. Innovation or stagnation: challenge and opportunity on the critical path to new medical products; 2004 [cited 2016 Dec 15]. Available from: http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/UCM113411.pdf.
  21. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The sequence of the human genome. Science 2001;291(5507):1304-1351. https://doi.org/10.1126/science.1058040
  22. Newmark PA, Sanchez Alvarado A. Not your father's planarian: a classic model enters the era of functional genomics. Nat Rev Genet 2002;3(3):210-219. https://doi.org/10.1038/nrg759
  23. Sundberg SA. High-throughput and ultra-high-throughput screening: solution- and cell-based approaches. Curr Opin Biotechnol 2000;11(1):47-53. https://doi.org/10.1016/S0958-1669(99)00051-8
  24. Tennant RW. The National Center for Toxicogenomics: using new technologies to inform mechanistic toxicology. Environ Health Perspect 2002;110(1):A8-A10. https://doi.org/10.1289/ehp.110-a8
  25. Krewski D, Acosta D Jr, Andersen M, Anderson H, Bailar JC 3rd, Boekelheide K, et al. Toxicity testing in the 21st century: a vision and a strategy. J Toxicol Environ Health B Crit Rev 2010;13(2-4):51-138. https://doi.org/10.1080/10937404.2010.483176
  26. Fentem J, Chamberlain M, Sangster B. The feasibility of replacing animal testing for assessing consumer safety: a suggested future direction. Altern Lab Anim 2004;32(6):617-623.
  27. Ashton R, De Wever B, Fuchs HW, Gaca M, Hill E, Krul C, et al. State of the art on alternative methods to animal testing from an industrial point of view: ready for regulation? ALTEX 2014;31(3):357-363. https://doi.org/10.14573/altex1403121
  28. Organization for Economic Cooperation and Development. Test No. 492: reconstructed human cornea-like epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eye damage; 2015 [cited 2016 Dec 26]. http://www.oecd-ilibrary.org/environment/test-no-492-reconstructed-human-cornea-like-epithelium-rhce-test-method-for-identifying-chemicals-not-requiring-classification-and-labelling-for-eye-irritation-or-serious-eye-damage_9789264242548-en.
  29. Debbasch C, Ebenhahn C, Dami N, Pericoi M, Van den Berghe C, Cottin M, et al. Eye irritation of low-irritant cosmetic formulations: correlation of in vitro results with clinical data and product composition. Food Chem Toxicol 2005;43(1):155-165. https://doi.org/10.1016/j.fct.2004.09.004
  30. Organization for Economic Cooperation and Development. Test No. 405: acute eye irritation/corrosion; 2012 [cited 2016 Dec 15]. Available from: http://www.oecd.org/env/test-no-405-acute-eye-irritationcorrosion-9789264185333-en.htm.
  31. Organization for Economic Cooperation and Development. Test No. 492: reconstructed human cornea-like epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eye damage; 2015 [cited 2016 Dec 15]. Available from: http://www.oecd-ilibrary.org/environment/test-no-492-reconstructed-human-cornea-like-epithelium-rhce-test-method-for-identifying-chemicals-not-requiring-classification-and-labelling-for-eye-irritation-or-serious-eye-damage_9789264242548-en.
  32. Organization for Economic Cooperation and Development. Test No. 429: skin sensitisation: local lymph node assay; 2010 [cited 2016 Dec 15]. Available from: http://www.oecd.org/env/test-no-429-skin-sensitisation-9789264071100-en.htm.
  33. Jaworska J, Harol A, Kern PS, Gerberick GF. Integrating non-animal test information into an adaptive testing strategy - skin sensitization proof of concept case. ALTEX 2011;28(3):211-225. https://doi.org/10.14573/altex.2011.3.211
  34. Tollefsen KE, Scholz S, Cronin MT, Edwards SW, de Knecht J, Crofton K, et al. Applying adverse outcome pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA). Regul Toxicol Pharmacol 2014;70(3):629-640. https://doi.org/10.1016/j.yrtph.2014.09.009
  35. National Institute of Environmental Research. National Institute of Environmental Research test guidelines for K-REACH: 2015-28 [cited 2016 Dec 15]. Available from: http://www.nier.go.kr/NIER/cop/bbs/selectNoLoginBoardList.do?bbsId=BBSMSTR_000000000031&menuNo=15001 (Korean).
  36. European Chemicals Agency. REACH legislation [cited 2016 Dec 26]. Available from: https://echa.europa.eu/regulations/reach/legislation.
  37. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86(2):420-428. https://doi.org/10.1037/0033-2909.86.2.420
  38. Home Office; Department for Business, Innovation & Skills; Department of Health. Working to reduce the use of animals in scientific research; 2014 [cited 2016 Dec 15]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/277942/bis-14-589-working-to-reduce-the-use-of_animals-in-research.pdf.

Cited by

  1. The Public Willingness to Pay for Reducing the Incidence of Hazardous Chemical Spill Accidents by Half in South Korea vol.10, pp.8, 2018, https://doi.org/10.3390/su10082673
  2. Determination of phthalates in particulate matter and gaseous phase emitted into the air of the working environment vol.17, pp.1, 2016, https://doi.org/10.1007/s13762-019-02435-y
  3. Evaluation of Stoffenmanager and a New Exposure Model for Estimating Occupational Exposure to Styrene in the Fiberglass Reinforced Plastics Lamination Process vol.17, pp.12, 2020, https://doi.org/10.3390/ijerph17124486
  4. Electron configuration-based neural network model to predict physicochemical properties of inorganic compounds vol.10, pp.55, 2016, https://doi.org/10.1039/d0ra05873d
  5. Green solvent-processed organic electronic devices vol.8, pp.43, 2020, https://doi.org/10.1039/d0tc03610b
  6. Routine exposure: social practices and environmental health risks in the home vol.18, pp.4, 2016, https://doi.org/10.1057/s41285-018-00084-8
  7. Editorial for “Materials Chemistry” Sections on Molecules vol.25, pp.24, 2016, https://doi.org/10.3390/molecules25245833
  8. Chemical risk in hospital settings: Overview on monitoring strategies and international regulatory aspects vol.10, pp.1, 2016, https://doi.org/10.4081/jphr.2021.1993
  9. Principal Component Analysis (PCA) Combined with Naturally Occurring Crystallization Inhibitors: An Integrated Strategy for a more Sustainable Control of Salt Decay in Built Heritage vol.4, pp.1, 2016, https://doi.org/10.3390/heritage4010013
  10. Safety Assessment of Endocrine Disruption by Menopausal Health Functional Ingredients vol.9, pp.10, 2021, https://doi.org/10.3390/healthcare9101376